A systematic review of ketamine for the treatment of depression among older adults
Farheen S, Gupta A, Dhar R, Patadia P, Funaro M, Bhattacharya G, Tampi R. A systematic review of ketamine for the treatment of depression among older adults. American Journal Of Geriatric Psychiatry 2021, 29: s93-s96. DOI: 10.1016/j.jagp.2021.01.089.Peer-Reviewed Educational MaterialsPrimary outcome measureUse of ketamineLate-life depressionTreatment of depressionOlder adultsElectroconvulsive therapyReceptor antagonistLife depressionOutcome measuresCurrent evidenceDepressive symptomsOlder subjectsHamilton Depression Rating Scale scoresN-methyl-D-aspartate receptor antagonistSystematic reviewStudy participantsDepression Rating Scale scoresAdverse effectsBenefits of ketamineTolerability of ketamineCognitive adverse effectsCochrane Central RegisterTreatment-resistant depressionAnti-depressant effectsRelapse of symptomsIs there evidence for using anticonvulsants in the prevention and/or treatment of delirium among older adults?
Bhattacharya G, Gupta A, Joshi P, Lehman M, Funaro M, Tampi D, Tampi R. Is there evidence for using anticonvulsants in the prevention and/or treatment of delirium among older adults? American Journal Of Geriatric Psychiatry 2021, 29: s136-s139. DOI: 10.1016/j.jagp.2021.01.131.Peer-Reviewed Educational MaterialsTreatment of deliriumRandomized control trialTotal knee replacementTotal hip replacementValproic acid preparationsPostoperative deliriumValproic acid derivativesPerioperative useSpinal surgeryOlder adultsCurrent evidenceElective total knee replacementElective total hip replacementAverage medical care costAcute neuropsychiatric syndromeCauses of deliriumUse of gabapentinManagement of deliriumNon-pharmacological strategiesCochrane Central RegisterNon-pharmacologic treatmentsHospitalized older adultsUse of anticonvulsantsIntensive care unitPalliative care setting